|
ZNF181 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.981200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.399400E-01 |
| Normal-vs-Stage2 |
3.763400E-01 |
| Normal-vs-Stage3 |
4.905000000055E-06 |
| Normal-vs-Stage4 |
1.55089999953617E-07 |
| Stage1-vs-Stage2 |
5.854600E-01 |
| Stage1-vs-Stage3 |
9.83340000000332E-05 |
| Stage1-vs-Stage4 |
7.87840000016082E-07 |
| Stage2-vs-Stage3 |
1.526350E-01 |
| Stage2-vs-Stage4 |
5.943800E-02 |
| Stage3-vs-Stage4 |
3.998000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.704800E-03 |
| Normal-vs-AfricanAmerican |
3.243200E-03 |
| Normal-vs-Asian |
1.608960E-01 |
| Caucasian-vs-AfricanAmerican |
2.410000E-01 |
| Caucasian-vs-Asian |
8.567400E-01 |
| AfricanAmerican-vs-Asian |
8.072400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.624900E-04 |
| Normal-vs-Female |
1.207810E-01 |
| Male-vs-Female |
8.666100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.813700E-04 |
| Normal-vs-Age(41-60Yrs) |
4.236100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.201400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.478000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.432000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.399970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.945400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.424400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.932000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.733600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.922000E-01 |
| Normal-vs-Grade 2 |
8.662200E-01 |
| Normal-vs-Grade 3 |
2.00959999999695E-05 |
| Normal-vs-Grade 4 |
3.59445806452641E-12 |
| Grade 1-vs-Grade 2 |
8.644400E-01 |
| Grade 1-vs-Grade 3 |
3.645500E-02 |
| Grade 1-vs-Grade 4 |
5.60250000000151E-05 |
| Grade 2-vs-Grade 3 |
1.95718999999039E-05 |
| Grade 2-vs-Grade 4 |
2.67419419941461E-12 |
| Grade 3-vs-Grade 4 |
3.9754000000003E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.066640E-01 |
| Normal-vs-ccB subtype |
1.65379999694792E-08 |
| ccA subtype-vs-ccB subtype |
4.01523259085934E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.358100E-03 |
| Normal-vs-N1 |
3.3990000003481E-07 |
| N0-vs-N1 |
1.322500E-03 |
|
|
